Twenty‐years experience with de novo metastatic breast cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|137|6|1417-1426

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.6, 2015-09, pp. : 1417-1426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of metastatic breast cancer in women aged 65 years and older

By Jolly Trevor   Williams Grant R   Jones Ellen   Muss Hyman B  

Women's Health, Vol. 8, Iss. 4, 2012-07 ,pp. : 455-471

Future Medicine

Access to resources Recommend Favorite

Everolimus in Metastatic Breast Cancer: Clinical Experience as a Late Treatment Line

By  

Oncology, Vol. 89, Iss. 6, 2015-10 ,pp. : 319-331

Karger

Access to resources Recommend Favorite

Lapatinib in metastatic breast cancer

By Frenel J-S   Bourbouloux E   Berton-Rigaud D   Sadot-Lebouvier S   Zanetti A   Campone M  

Women's Health, Vol. 5, Iss. 6, 2009-11 ,pp. : 603-612

Future Medicine

Access to resources Recommend Favorite

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 228-237

Karger

Access to resources Recommend Favorite

Docetaxel Weekly with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 30, Iss. 8-9, 2007-09 ,pp. : 407-408

Karger

Access to resources Recommend Favorite